口腔癌患者手术前后免疫球蛋白和补体检测及其临床意义
|
摘要
目的:采用临床常用的体液免疫功能检测方法,观察口腔癌患者手术前后免疫球蛋白和补体浓度变化,初步探讨外科手术对口腔癌患者免疫系统的影响。
方法:采用全自动特定蛋白分析仪定量测定了16例口腔癌患者手术前、手术后第3天及第10天外周血免疫球蛋白(IgG、IgA、IgM、IgE)、补体(C3和C4)浓度,比较不同临床分期,术前、术后不同时间段内口腔癌患者免疫球蛋白、补体浓度变化。
结果:
(1)口腔癌患者术前、术后第3天、术后第10天机体免疫球蛋白(IgG、IgA、IgM、IgE)和补体(C3和C4)浓度对于临床分期Ⅰ-Ⅱ期和Ⅲ-Ⅳ期相比均无显著性差别(P＞0.05);
(2)口腔癌患者术前、术后第3天、术后第10天机体免疫球蛋白IgG、IgA、IgE和补体C4浓度相互比较均无显著性差别(P＞0.05);
口腔癌患者术后第10天IgM浓度比术前、术后第3天明显升高(P＜0.05),口腔癌患者术前、术后第3天IgM浓度相互比较无显著性差别(P＞0.05);
口腔癌患者术后第3天、第10天C3浓度分别和术前相比有明显升高(P＜0.05),口腔癌患者术后第3天和第10天C3浓度相比无显著性差别(P＞0.05);
(3)口腔癌患者术前、术后第3天、术后第10天免疫球蛋白(IgG、IgA、IgM、IgE)和补体(C3和C4)浓度男女间相比均无显著性差别(P＞0.05)。
结论:
(1)不同临床分期的口腔癌患者机体免疫球蛋白(IgG、IgA、IgM、IgE)和补体(C3和C4)浓度无差别;
(2)口腔癌患者术前术后机体免疫球蛋白(IgG、IgA、IgE)和补体C4浓度无变化;但是IgM、C3浓度有短暂升高,提示口腔癌联合根治术对患者术后免疫球蛋白和补体浓度变化影响有限;
(3)采用临床常用的体液免疫功能检测方法评价口腔癌患者手术前后免疫球蛋白和补体浓度变化的意义有待进一步研究。
Objectives: Clinical serum immune function commonly used detection method to observe immunoglobulin and complements for patients with oral cancer undergoing operation ,in the preliminary study on oral cancer surgery in patients with immune system effects.
Methods: Peripheral blood was taken from 16 patients with oral cancer before operation and the third day and the tenth day after operation by automatic analysis machine of protein-specific quantitative detecting in immunoglobulin (IgG, IgA, IgM, IgE) and complements (C3 and C4) to compare the concentration in immunoglobulin and complements for patients with oral cancer of different clinical stages, different time period before and after operation .
Results:
(1) The concentration of immunoglobulin (IgG, IgA, IgM, IgE) and complements (C3 and C4) for patients with oral cancer before operation and the third day and the tenth day after operation between the clinical stage I-II and III-IV was no significant difference (P> 0.05).
(2) The concentration of immunoglobulin(IgG, IgA, IgM, IgE) and complements (C3 and C4) for patients with oral cancer before operation and the third day and the tenth day after operation compared no significant difference (P> 0.05).
The concentration of IgM of the tenth day after operation was than those of before operation and the third day after operation increased significantly (P <0.05), but between the concentration of IgM of before operation and the third day there was no significant difference (P > 0.05).
The concentration of C3 of the third day and the tenth day after operation was than that of before operation increased significantly (P <0.05), but between the concentration of C3 of the third day and the tenth day after operation there was no significant difference (P > 0.05).
(3) The concentration of immunoglobulin(IgG, IgA, IgM, IgE) and complements (C3 and C4) for patients with oral cancer before operation and the third day and the tenth day after operation between men and women there was no significant difference (P>0.05).
Conclusion:
(1) The concentration of immunoglobulin (IgG, IgA, IgM, IgE) and complements (C3 and C4)for patients with oral cancer in different clinical stages was non-discrimination.
(2) The concentration of immunoglobulin (IgG, IgA, IgE) and complement (C3) for patients with oral cancer undergoing operation was non-discrimination, but the concentration of IgM, C3 was short-term increase, suggesting that the patients with oral cance after the radical surgery on the concentration of immunoglobulin and complements in a limited impact.
(3) Clinical serum immune function commonly used detection method to observe immunoglobulin and complements for patients with oral cancer undergoing operation is to be studied further.
方法:采用全自动特定蛋白分析仪定量测定了16例口腔癌患者手术前、手术后第3天及第10天外周血免疫球蛋白(IgG、IgA、IgM、IgE)、补体(C3和C4)浓度,比较不同临床分期,术前、术后不同时间段内口腔癌患者免疫球蛋白、补体浓度变化。
结果:
(1)口腔癌患者术前、术后第3天、术后第10天机体免疫球蛋白(IgG、IgA、IgM、IgE)和补体(C3和C4)浓度对于临床分期Ⅰ-Ⅱ期和Ⅲ-Ⅳ期相比均无显著性差别(P＞0.05);
(2)口腔癌患者术前、术后第3天、术后第10天机体免疫球蛋白IgG、IgA、IgE和补体C4浓度相互比较均无显著性差别(P＞0.05);
口腔癌患者术后第10天IgM浓度比术前、术后第3天明显升高(P＜0.05),口腔癌患者术前、术后第3天IgM浓度相互比较无显著性差别(P＞0.05);
口腔癌患者术后第3天、第10天C3浓度分别和术前相比有明显升高(P＜0.05),口腔癌患者术后第3天和第10天C3浓度相比无显著性差别(P＞0.05);
(3)口腔癌患者术前、术后第3天、术后第10天免疫球蛋白(IgG、IgA、IgM、IgE)和补体(C3和C4)浓度男女间相比均无显著性差别(P＞0.05)。
结论:
(1)不同临床分期的口腔癌患者机体免疫球蛋白(IgG、IgA、IgM、IgE)和补体(C3和C4)浓度无差别;
(2)口腔癌患者术前术后机体免疫球蛋白(IgG、IgA、IgE)和补体C4浓度无变化;但是IgM、C3浓度有短暂升高,提示口腔癌联合根治术对患者术后免疫球蛋白和补体浓度变化影响有限;
(3)采用临床常用的体液免疫功能检测方法评价口腔癌患者手术前后免疫球蛋白和补体浓度变化的意义有待进一步研究。
Objectives: Clinical serum immune function commonly used detection method to observe immunoglobulin and complements for patients with oral cancer undergoing operation ,in the preliminary study on oral cancer surgery in patients with immune system effects.
Methods: Peripheral blood was taken from 16 patients with oral cancer before operation and the third day and the tenth day after operation by automatic analysis machine of protein-specific quantitative detecting in immunoglobulin (IgG, IgA, IgM, IgE) and complements (C3 and C4) to compare the concentration in immunoglobulin and complements for patients with oral cancer of different clinical stages, different time period before and after operation .
Results:
(1) The concentration of immunoglobulin (IgG, IgA, IgM, IgE) and complements (C3 and C4) for patients with oral cancer before operation and the third day and the tenth day after operation between the clinical stage I-II and III-IV was no significant difference (P> 0.05).
(2) The concentration of immunoglobulin(IgG, IgA, IgM, IgE) and complements (C3 and C4) for patients with oral cancer before operation and the third day and the tenth day after operation compared no significant difference (P> 0.05).
The concentration of IgM of the tenth day after operation was than those of before operation and the third day after operation increased significantly (P <0.05), but between the concentration of IgM of before operation and the third day there was no significant difference (P > 0.05).
The concentration of C3 of the third day and the tenth day after operation was than that of before operation increased significantly (P <0.05), but between the concentration of C3 of the third day and the tenth day after operation there was no significant difference (P > 0.05).
(3) The concentration of immunoglobulin(IgG, IgA, IgM, IgE) and complements (C3 and C4) for patients with oral cancer before operation and the third day and the tenth day after operation between men and women there was no significant difference (P>0.05).
Conclusion:
(1) The concentration of immunoglobulin (IgG, IgA, IgM, IgE) and complements (C3 and C4)for patients with oral cancer in different clinical stages was non-discrimination.
(2) The concentration of immunoglobulin (IgG, IgA, IgE) and complement (C3) for patients with oral cancer undergoing operation was non-discrimination, but the concentration of IgM, C3 was short-term increase, suggesting that the patients with oral cance after the radical surgery on the concentration of immunoglobulin and complements in a limited impact.
(3) Clinical serum immune function commonly used detection method to observe immunoglobulin and complements for patients with oral cancer undergoing operation is to be studied further.
引文
[1]陈慰峰.医学免疫学[M].第3版.北京:人民卫生出版社,2000:226-235.
[2]Ohwada S,Line Y,NaKamura S,et al.Peripheral blood T cell subsets as a prognostic Factor in gastric cancer[J].Jpn J Clin Oncol,1994,24:7.
[3]凌华.补体与肿瘤发展的关系[J].国外医学·生理、病理科学与临床分册,1993,13(1):14.
[4]王明德,王苏河,林朵英等.舌鳞癌患者手术前后免疫状态的检测[J].福建医学院报,1990,24(4):288-230.
[5]伏亚琴,田粮,李芳文.头颈癌患者T淋巴细胞亚群及体液免疫的检测[J].兰州医学院学报,1992,18(2):101-103.
[6]肖先缜,赵福远,许平等.口腔颌面部癌瘤患者手术前后周围血中T细胞亚群、免疫球蛋白的变化[J].口腔现代医学杂志,1994,8(2):102
[7]Harbans L,el at.Serum immunoglobulin E levels in patients with head and neck cancer.[J]Laryngol Otal,1988,102:432.
[8]Scully C.Immunological abnormalities in oral carcinema and oral keratosis[J].MaxillofacSurg,1982,10(2):113-115.
[9]Rajendran R,et al.Cell mediated and humoral immune responses in oral submucous fibrosis[J].Cancer.1986,58(12):2628-2631.
[10]Satto T,Shimoda K,Kinoshtta T,et al.Prediction of ope-ractive mortality based on impairment of host defense system in patient with esophageal cancer[J].Surg Oncol,1993,52:1-2.
[11]Tsutsui S Ⅱ,Mortta M,Kuwano Ⅱ,et al.Influence of preoperative treatment and surgical operation on immune function of patient with esophageal carcinoma[J].Surg Oncol,1992,49:176-177.
[12]徐令巽.应用T淋巴细胞亚群单克隆抗体对肿瘤病人免疫状态的检测[J].中华肿瘤杂志,1985,7(2):991.
[13]van derMerwe PA.Formation and function of the immunological synapes [J].CurrOpin Imm unol,2002,14(3):293-298.
[14]Vyas YM,Mehta KM,Morgan M,et al.Spatial organization of signal transduction molecules in the NK cell immune synap ses during MHC class I2regulatednoncytolytic and cytolytic interactions[J].J Immunol,2001,167(8):4358-4367.
[15]Takasugi M,Ramseyer A,Takasugi M,Decline of natural nonselective cellmediated cytotoxicity in patients with tumor progression[J].Cancer Res,1997,37:413-418.
[16]王虹,封兴华.口腔颌面肿瘤唾液癌胚抗原及IgA测定和临床意义[J].实用口腔医学杂志,1999,15(6):447.
[17]李和平,杨立珍,孙涌泉,等.口腔鳞状细胞癌患者血清IgE的检测与评价[J].实用口腔医学杂志,1996,12(3):180-182.
[18]叶冬霞,徐驳,陈万涛,等.口腔癌患者手术前后外周血免疫指标的检测及其临床意义[J].上海口腔医学,2004,13(2):83-86.
[19]徐华.手术应激反应研究进展[J].《国外医学》麻醉学与复苏分册,2003,24(5):278-281.
[20]黄勇,刘建伟.术前一次给予地塞米松对结肠癌患者免疫功能的影响.岭南现代临床外科,2008,8(1):26-28.
[21]周青山,余金甫.麻醉与免疫系统的功能[J].中华麻醉学杂志,1998,11:702-704.
[22]Procopio MA,Rassias AJ,DeLeo JA,et al.The in vivo effects of general and epidural anesthesia on human immune function[J].Anesth Analg,2001,93(2):460-465.
[22]施培青,马正美,邱谷,等.不同麻醉方法对围手术期应激反应的影响[J].牡丹江医学院学报,2001,22(3):3-6.
[23]王晓华.癌症患者睡眠质量与心理健康状况调查分析[J].中国康复理论与实践,2005,11(9):737-739.
[24]Mssise MJ.Holland JC.Depression and the cancer patient[J].ClinPsycharty,1990,51:12.
[25]Silberb Pm:Psychiarric treatment of the patient during cancer therapy[J].CA 1988,38(3):133.
[26]董毅,邵厚云,刘巍.癌症患者的抑郁调查与分析[J].中国临床心理学杂志,1994,2(4):235.
[27]李宁,乐小渡.100例癌症患者的情绪障碍分析[J].中国肿瘤临床与康复,1995.2(4):48.
[28]李景梅,常晓丽.住院肿瘤患者睡眠质量及影响因素调查分析[J].中华临床新医学,2005,5(8):759.
[29]陈伟程.口腔癌患者术后睡眠状况调查与相关因素分析[硕士学位论文].长沙:中南大学,2008.
[30]Satto T,Shlmoda K,Kinoshita T,etal.prediction of operactive mortality based on impairment of host defense systems in patients with esophageal cancer[J].Surg Oncol,1993,52(1):1-8.
[31]赵玉霞,蔡峰,王志宇,等.肺癌患者体液免疫状态与放疗效果的临床分析[J].大连医科大学学报,2006,28(3):195-196.
[32]成国建.食管癌患者血清免疫球蛋白与补体C3测定对放射治疗预后分析[J].肿瘤基础与临床,2006,19(1):38-39
[33]Kolebacz B.Concentrations of selected acute phase proteins and immunity immunoglobulins in the treatment of head and neck carcinomas[J].Otolaryngol Pol.1999;53(6):743-6.
[1]杨镇.肿瘤免疫学[M].武汉:湖北科学技术出版社,1998,106.
[2]Ohwada S,Line Y,NaKamura S,et al.Peripheral blood T cell subsets as a prognostic Factor in gastric cancer[J].Jpn J Clin Oncol,1994,24:7.
[3]黄大有.实验诊断的理论基础和临床意义[M].第二版.北京;人民卫生出版杜,1985;373.
[4]肖先缜,赵福远,许平等.口腔颌面部癌瘤患者手术前后周围血中T细胞亚群、免疫球蛋白的变化[J].口腔现代医学杂志,1994,8(2):102.
[5]王明德,王苏河,林朵英等.舌鳞癌患者手术前后免疫状态的检测.福建医学院报[J],1990,24(4):288-230.
[6]伏亚琴,田粮,李芳文.头颈癌患者T淋巴细胞亚群及体液免疫的检测.兰州医学院学报[J],1992,18(2):101-103.
[7]郑仁瑞,周友泉,史彩虹,恶性肿瘤患者T细胞亚群和免疫球蛋白检测分析[J].中国医药卫生,2005,6(15):9-10.
[8]Fearon ER,Cho KR,Nigro JM,et al.Identification of a chromo some 18 q gene that is altered in colorectal cancers[J].Science,1990,247:49.
[9]梅强,陈克能,师晓天.食管癌患者若干体液免疫功能的变化及其影响因素[J].中国肿瘤临床与康复,1999,6(1):25-26.
[10]黄雪芳,王三英,彭宣宪,等.恶性肿瘤患者血清中免疫球蛋白类型的剖析观察[J].中国肿瘤临床,1998,25(8):597-600.
[11]Mosman TR,Coffman RL.Thl and Th2 cells:Different patterns of lymphokine secretion lead to different functional properties[J].Annu Rev Immunol,1989,7:145.
[12]Romagnani S,Maggi E,Prete GD.An alternative view of the TH1/Th2switch hypothesis in H IV infection[J].AIDS Res Hum Retrov,1994,10:3.
[13]Nanda NK and Serearz EE.Induction of anti—self—immunity tocure cancer[J].Cell,1995,(82):13.
[14]Scully C.Immunological abnormalities in oral carcinema and oral keratosis[J].Maxillofac Surg,1982,10(2):113-115.
[15]Rajendran R,et al.Cell mediated and humoral immune responses in oral submucous fibrosis[J].Cancer.1986,58(12):2628-2631.
[16]陈巧伦,梁伊红.T淋巴细胞核仁形成区嗜银蛋白检测对肿瘤的意义的探讨[J].肿瘤,2002,(6):506.
[17]王虹,封兴华.口腔颌面肿瘤唾液癌胚抗原及IgA测定和临床意义[J].实用口腔医学杂志,1999,15(6):447.
[18]Kolebacz B.Concentrations of selected acute phase proteins and immunity immunoglobulins in the treatment of head and neck carcinomas[J].Otolaryngol Pol.1999;53(6):743-746.
[19]Vijayakumar T.et al.Serum immunoglobulins in patients with carcinoma Of the oral cavity,uterine cervix and breast cancer[J].Cancer Immunol Immunother,1986,22(1):76-79.
[20]Harbans L,el at.Serum immunoglobulin E levels in patients with head and neck cancer[J].Laryngol Otal,1988,102:432.
[21]Serrou B,Dubois B.IgE serrum levels in cancer patients[J].Lancet,1975,1:396.
[22]Waldmann T A,et al.Serum immunoglobulin E levels in patients with neoplastic disease[J].Immunol.1974,113:379.
[23]Mayer BA,Enzmann H.Dynamics and significance of immunoglobulin E (IgE)as an immunological parameter in squamous cell carcinomas of the oral cavity and pharynx[J].Laryngol Rhinol Otol(Stuttg).1987,66(6):316-319.
[24]李和平,杨立珍,孙涌泉,等.口腔鳞状细胞癌患者血清IgE的检测与评价[J].实用口腔医学杂志,1996,12(3):180-182.
[25]凌华.补体与肿瘤发展的关系[J].国外医学·生理、病理科学与临床分册,1993,13(1):14.
[26]Walport MJ.Complement Second of two parts[J].N Engl J Med,2001,344(15):1140-1144.
[27]Jurianz K,Ziegler S,Garcia-Schuler H,et al.Complement resistance of tumor cells:basal and induced mechanisms[J].Mol Immunol,1999,36(13- 141:929-939.
[28]陈慰峰.医学免疫学[M].第3版.北京:人民卫生出版社,2000:35-52.
[29]Satto T,Shlmoda K,Kinoshita T,et al.prediction ofoperactive mortality based on impairment of host defense systems in patients with esophageal cancer[J].SurgOncol,1993,52(1):1-8.
[30]李占武;马素芳;史光军;胡义利;血清补体在肝癌诊断中的价值[J],华北煤炭医学院学报,2001,3(2):141-142.
[31]吴桂荣,庄永敬,王俊津,等.血清总补体水平与肝癌病理类型关系[J].肿瘤研究临床,2000,12(4):235.
[32]江素华,李字清,关广雄,等.肝癌患者74例免疫球蛋白、补体水平及AFP分析[J].中国肿瘤临床与康复,2002,9(6):35.
[33]Lavedan P,Savage E,Lee Y,et al.Circulating Clq-binding macromolecles and their relationship to radiographic characteristics of laryngeal cancer[J].Arch Otolaryngol Head NeckSurg,1991,117(3):292.
[34]Tomeczko-J,Napora-p,Dlubek-D,et al.Adjuvant spleen ultrafiltrate immunotherapy in unresectable advanced non small cell lung cancer[J]Arzneimittelforschung,1997,47(12):1411-1416.
[35]Fujita-T;Hara-A;Yamazaki-Y.The value of acute-phase protein measurements after curative gastric cancer surgery[J].Arch Surg,1999,134(1):73-75.
[36]孙彦,王琪.2002年AJCC喉癌分期方案[J].国外医学·耳鼻咽喉科学分册,2004,28(4):248.
[37]李巍;,何尔斯泰,张学英,等.肿瘤与补体的临床意义探讨[J],吉林医学,1993,14(2):82-83.
[38]陈国建,邵松崔,相法.妇科肿瘤患者手术前后补体水平的变化[J].江西医学检验,2002,20(2):111.
[39]李景梅,常晓丽.住院肿瘤患者睡眠质量及影响因素调查分析[J].中华临床新医学,2005,5(8):759.
[40]马自立,范士怀葛来增,等.癌症疼痛与机体免疫水平关系的临床研究[J].中华疼痛医学杂志,1999,5(3):133-135.
[41]马建青.三阶梯止痛对癌症患者机体免疫水平的影响.四川医学,2006,27(11):1127-1128.
[42]王晓华.癌症患者睡眠质量与心理健康状况调查分析[J].中国康复理论与实践,2005,11(9):737-739.
[43]Mssise MJ.Holland JC.Depression and the cancer patient[J].ClinPsyclharty.1990,51:12
[44]Silberb Pro:Psychiatric treatment of the patient during cancer therapy[J].CA 1988,38(3):133
[45]董毅,邵厚云,刘巍.癌症患者的抑郁调查与分析[J].中国临床心理学杂志,1994,2(4):235.
[46]李宁,乐小渡.100例癌症患者的情绪障碍分析[J].中国肿瘤临床与康复,1995.2(4):48.
[47]郑勇斌,简莉莉,刘培生,等.心理干预对手术病人免疫功能的影响[J].实用临床医学,2002,16(1):5-15.
[48]周青山,余金甫.麻醉与免疫系统的功能[J].中华麻醉学杂志,1998,11:702-704.
[49]Procopio MA,Rassias A J,DeLeo JA,et al.The in vivo effects of general and epidural anesthesia on human immune function[J].Anesth Analg,2001,93(2):460-465.
[50]施培青,马正美,邱谷,等.不同麻醉方法对围手术期应激反应的影响[J].牡丹江医学院学报,2001,22(3):3-6.
[51]陈立武,杜建,黄铭涵,等.Ⅲ期胃肠道肿瘤患者围手术期细胞疫功能的动态观察[J].现代肿瘤医学,2007,15(6):813-815.
[52]Hansbrough J F,Bender EM,Sirvent RZ,et al.Altered helper and suppressor lymphocyte populztions in surgical patients[J].Am J Surg,1984,148:303-305.
[53]焦志华.麻醉、手术对肿瘤患者细胞免疫的影响[J].国外医学麻醉学 与复苏分册,2002,23(5):303-305.
[54]Esposito S.Immune system and surgical site infection[J].J Chemother,2001,13(1):12-16.
[55]陈主初,王树人.病理生理学[M].北京,人民卫生出版社,2001,219-223.
[56]Wang L,Das H,Kamath A,et al.Human V gamma 2V delta2 T cells augment migration-inhibitory factor secretion andcounteract the inhibitory effect of glucocorticoids on IL-1 beta and TNF-alpha production[J].J Immunol,2002,168(10):4889-4896.
[57]徐华.手术应激反应研究进展[J].《国外医学》麻醉学与复苏分册,2003,24(5):278-281.
[58]黄勇,刘建伟.术前一次给予地塞米松对结肠癌患者免疫功能的影响[J].岭南现代临床外科,2008,8(1):26-28
[59]Na YM,Kim MY,Kim YK,et al.Exercise therapy effect on natural killer cell cytotoxic activity in stomach cancer patients after curative surgery[J].Arch Phys Med Rehabil,2000,81:777-779.
[60]Herhman MJ,Cheadle WG,Wellhausen SR,et al.Monocyte HLA2 DR antigen expression characterizes clinical outcome in the trauma patient[J].Br J Surg,1990,77:204.
[2]Ohwada S,Line Y,NaKamura S,et al.Peripheral blood T cell subsets as a prognostic Factor in gastric cancer[J].Jpn J Clin Oncol,1994,24:7.
[3]凌华.补体与肿瘤发展的关系[J].国外医学·生理、病理科学与临床分册,1993,13(1):14.
[4]王明德,王苏河,林朵英等.舌鳞癌患者手术前后免疫状态的检测[J].福建医学院报,1990,24(4):288-230.
[5]伏亚琴,田粮,李芳文.头颈癌患者T淋巴细胞亚群及体液免疫的检测[J].兰州医学院学报,1992,18(2):101-103.
[6]肖先缜,赵福远,许平等.口腔颌面部癌瘤患者手术前后周围血中T细胞亚群、免疫球蛋白的变化[J].口腔现代医学杂志,1994,8(2):102
[7]Harbans L,el at.Serum immunoglobulin E levels in patients with head and neck cancer.[J]Laryngol Otal,1988,102:432.
[8]Scully C.Immunological abnormalities in oral carcinema and oral keratosis[J].MaxillofacSurg,1982,10(2):113-115.
[9]Rajendran R,et al.Cell mediated and humoral immune responses in oral submucous fibrosis[J].Cancer.1986,58(12):2628-2631.
[10]Satto T,Shimoda K,Kinoshtta T,et al.Prediction of ope-ractive mortality based on impairment of host defense system in patient with esophageal cancer[J].Surg Oncol,1993,52:1-2.
[11]Tsutsui S Ⅱ,Mortta M,Kuwano Ⅱ,et al.Influence of preoperative treatment and surgical operation on immune function of patient with esophageal carcinoma[J].Surg Oncol,1992,49:176-177.
[12]徐令巽.应用T淋巴细胞亚群单克隆抗体对肿瘤病人免疫状态的检测[J].中华肿瘤杂志,1985,7(2):991.
[13]van derMerwe PA.Formation and function of the immunological synapes [J].CurrOpin Imm unol,2002,14(3):293-298.
[14]Vyas YM,Mehta KM,Morgan M,et al.Spatial organization of signal transduction molecules in the NK cell immune synap ses during MHC class I2regulatednoncytolytic and cytolytic interactions[J].J Immunol,2001,167(8):4358-4367.
[15]Takasugi M,Ramseyer A,Takasugi M,Decline of natural nonselective cellmediated cytotoxicity in patients with tumor progression[J].Cancer Res,1997,37:413-418.
[16]王虹,封兴华.口腔颌面肿瘤唾液癌胚抗原及IgA测定和临床意义[J].实用口腔医学杂志,1999,15(6):447.
[17]李和平,杨立珍,孙涌泉,等.口腔鳞状细胞癌患者血清IgE的检测与评价[J].实用口腔医学杂志,1996,12(3):180-182.
[18]叶冬霞,徐驳,陈万涛,等.口腔癌患者手术前后外周血免疫指标的检测及其临床意义[J].上海口腔医学,2004,13(2):83-86.
[19]徐华.手术应激反应研究进展[J].《国外医学》麻醉学与复苏分册,2003,24(5):278-281.
[20]黄勇,刘建伟.术前一次给予地塞米松对结肠癌患者免疫功能的影响.岭南现代临床外科,2008,8(1):26-28.
[21]周青山,余金甫.麻醉与免疫系统的功能[J].中华麻醉学杂志,1998,11:702-704.
[22]Procopio MA,Rassias AJ,DeLeo JA,et al.The in vivo effects of general and epidural anesthesia on human immune function[J].Anesth Analg,2001,93(2):460-465.
[22]施培青,马正美,邱谷,等.不同麻醉方法对围手术期应激反应的影响[J].牡丹江医学院学报,2001,22(3):3-6.
[23]王晓华.癌症患者睡眠质量与心理健康状况调查分析[J].中国康复理论与实践,2005,11(9):737-739.
[24]Mssise MJ.Holland JC.Depression and the cancer patient[J].ClinPsycharty,1990,51:12.
[25]Silberb Pm:Psychiarric treatment of the patient during cancer therapy[J].CA 1988,38(3):133.
[26]董毅,邵厚云,刘巍.癌症患者的抑郁调查与分析[J].中国临床心理学杂志,1994,2(4):235.
[27]李宁,乐小渡.100例癌症患者的情绪障碍分析[J].中国肿瘤临床与康复,1995.2(4):48.
[28]李景梅,常晓丽.住院肿瘤患者睡眠质量及影响因素调查分析[J].中华临床新医学,2005,5(8):759.
[29]陈伟程.口腔癌患者术后睡眠状况调查与相关因素分析[硕士学位论文].长沙:中南大学,2008.
[30]Satto T,Shlmoda K,Kinoshita T,etal.prediction of operactive mortality based on impairment of host defense systems in patients with esophageal cancer[J].Surg Oncol,1993,52(1):1-8.
[31]赵玉霞,蔡峰,王志宇,等.肺癌患者体液免疫状态与放疗效果的临床分析[J].大连医科大学学报,2006,28(3):195-196.
[32]成国建.食管癌患者血清免疫球蛋白与补体C3测定对放射治疗预后分析[J].肿瘤基础与临床,2006,19(1):38-39
[33]Kolebacz B.Concentrations of selected acute phase proteins and immunity immunoglobulins in the treatment of head and neck carcinomas[J].Otolaryngol Pol.1999;53(6):743-6.
[1]杨镇.肿瘤免疫学[M].武汉:湖北科学技术出版社,1998,106.
[2]Ohwada S,Line Y,NaKamura S,et al.Peripheral blood T cell subsets as a prognostic Factor in gastric cancer[J].Jpn J Clin Oncol,1994,24:7.
[3]黄大有.实验诊断的理论基础和临床意义[M].第二版.北京;人民卫生出版杜,1985;373.
[4]肖先缜,赵福远,许平等.口腔颌面部癌瘤患者手术前后周围血中T细胞亚群、免疫球蛋白的变化[J].口腔现代医学杂志,1994,8(2):102.
[5]王明德,王苏河,林朵英等.舌鳞癌患者手术前后免疫状态的检测.福建医学院报[J],1990,24(4):288-230.
[6]伏亚琴,田粮,李芳文.头颈癌患者T淋巴细胞亚群及体液免疫的检测.兰州医学院学报[J],1992,18(2):101-103.
[7]郑仁瑞,周友泉,史彩虹,恶性肿瘤患者T细胞亚群和免疫球蛋白检测分析[J].中国医药卫生,2005,6(15):9-10.
[8]Fearon ER,Cho KR,Nigro JM,et al.Identification of a chromo some 18 q gene that is altered in colorectal cancers[J].Science,1990,247:49.
[9]梅强,陈克能,师晓天.食管癌患者若干体液免疫功能的变化及其影响因素[J].中国肿瘤临床与康复,1999,6(1):25-26.
[10]黄雪芳,王三英,彭宣宪,等.恶性肿瘤患者血清中免疫球蛋白类型的剖析观察[J].中国肿瘤临床,1998,25(8):597-600.
[11]Mosman TR,Coffman RL.Thl and Th2 cells:Different patterns of lymphokine secretion lead to different functional properties[J].Annu Rev Immunol,1989,7:145.
[12]Romagnani S,Maggi E,Prete GD.An alternative view of the TH1/Th2switch hypothesis in H IV infection[J].AIDS Res Hum Retrov,1994,10:3.
[13]Nanda NK and Serearz EE.Induction of anti—self—immunity tocure cancer[J].Cell,1995,(82):13.
[14]Scully C.Immunological abnormalities in oral carcinema and oral keratosis[J].Maxillofac Surg,1982,10(2):113-115.
[15]Rajendran R,et al.Cell mediated and humoral immune responses in oral submucous fibrosis[J].Cancer.1986,58(12):2628-2631.
[16]陈巧伦,梁伊红.T淋巴细胞核仁形成区嗜银蛋白检测对肿瘤的意义的探讨[J].肿瘤,2002,(6):506.
[17]王虹,封兴华.口腔颌面肿瘤唾液癌胚抗原及IgA测定和临床意义[J].实用口腔医学杂志,1999,15(6):447.
[18]Kolebacz B.Concentrations of selected acute phase proteins and immunity immunoglobulins in the treatment of head and neck carcinomas[J].Otolaryngol Pol.1999;53(6):743-746.
[19]Vijayakumar T.et al.Serum immunoglobulins in patients with carcinoma Of the oral cavity,uterine cervix and breast cancer[J].Cancer Immunol Immunother,1986,22(1):76-79.
[20]Harbans L,el at.Serum immunoglobulin E levels in patients with head and neck cancer[J].Laryngol Otal,1988,102:432.
[21]Serrou B,Dubois B.IgE serrum levels in cancer patients[J].Lancet,1975,1:396.
[22]Waldmann T A,et al.Serum immunoglobulin E levels in patients with neoplastic disease[J].Immunol.1974,113:379.
[23]Mayer BA,Enzmann H.Dynamics and significance of immunoglobulin E (IgE)as an immunological parameter in squamous cell carcinomas of the oral cavity and pharynx[J].Laryngol Rhinol Otol(Stuttg).1987,66(6):316-319.
[24]李和平,杨立珍,孙涌泉,等.口腔鳞状细胞癌患者血清IgE的检测与评价[J].实用口腔医学杂志,1996,12(3):180-182.
[25]凌华.补体与肿瘤发展的关系[J].国外医学·生理、病理科学与临床分册,1993,13(1):14.
[26]Walport MJ.Complement Second of two parts[J].N Engl J Med,2001,344(15):1140-1144.
[27]Jurianz K,Ziegler S,Garcia-Schuler H,et al.Complement resistance of tumor cells:basal and induced mechanisms[J].Mol Immunol,1999,36(13- 141:929-939.
[28]陈慰峰.医学免疫学[M].第3版.北京:人民卫生出版社,2000:35-52.
[29]Satto T,Shlmoda K,Kinoshita T,et al.prediction ofoperactive mortality based on impairment of host defense systems in patients with esophageal cancer[J].SurgOncol,1993,52(1):1-8.
[30]李占武;马素芳;史光军;胡义利;血清补体在肝癌诊断中的价值[J],华北煤炭医学院学报,2001,3(2):141-142.
[31]吴桂荣,庄永敬,王俊津,等.血清总补体水平与肝癌病理类型关系[J].肿瘤研究临床,2000,12(4):235.
[32]江素华,李字清,关广雄,等.肝癌患者74例免疫球蛋白、补体水平及AFP分析[J].中国肿瘤临床与康复,2002,9(6):35.
[33]Lavedan P,Savage E,Lee Y,et al.Circulating Clq-binding macromolecles and their relationship to radiographic characteristics of laryngeal cancer[J].Arch Otolaryngol Head NeckSurg,1991,117(3):292.
[34]Tomeczko-J,Napora-p,Dlubek-D,et al.Adjuvant spleen ultrafiltrate immunotherapy in unresectable advanced non small cell lung cancer[J]Arzneimittelforschung,1997,47(12):1411-1416.
[35]Fujita-T;Hara-A;Yamazaki-Y.The value of acute-phase protein measurements after curative gastric cancer surgery[J].Arch Surg,1999,134(1):73-75.
[36]孙彦,王琪.2002年AJCC喉癌分期方案[J].国外医学·耳鼻咽喉科学分册,2004,28(4):248.
[37]李巍;,何尔斯泰,张学英,等.肿瘤与补体的临床意义探讨[J],吉林医学,1993,14(2):82-83.
[38]陈国建,邵松崔,相法.妇科肿瘤患者手术前后补体水平的变化[J].江西医学检验,2002,20(2):111.
[39]李景梅,常晓丽.住院肿瘤患者睡眠质量及影响因素调查分析[J].中华临床新医学,2005,5(8):759.
[40]马自立,范士怀葛来增,等.癌症疼痛与机体免疫水平关系的临床研究[J].中华疼痛医学杂志,1999,5(3):133-135.
[41]马建青.三阶梯止痛对癌症患者机体免疫水平的影响.四川医学,2006,27(11):1127-1128.
[42]王晓华.癌症患者睡眠质量与心理健康状况调查分析[J].中国康复理论与实践,2005,11(9):737-739.
[43]Mssise MJ.Holland JC.Depression and the cancer patient[J].ClinPsyclharty.1990,51:12
[44]Silberb Pro:Psychiatric treatment of the patient during cancer therapy[J].CA 1988,38(3):133
[45]董毅,邵厚云,刘巍.癌症患者的抑郁调查与分析[J].中国临床心理学杂志,1994,2(4):235.
[46]李宁,乐小渡.100例癌症患者的情绪障碍分析[J].中国肿瘤临床与康复,1995.2(4):48.
[47]郑勇斌,简莉莉,刘培生,等.心理干预对手术病人免疫功能的影响[J].实用临床医学,2002,16(1):5-15.
[48]周青山,余金甫.麻醉与免疫系统的功能[J].中华麻醉学杂志,1998,11:702-704.
[49]Procopio MA,Rassias A J,DeLeo JA,et al.The in vivo effects of general and epidural anesthesia on human immune function[J].Anesth Analg,2001,93(2):460-465.
[50]施培青,马正美,邱谷,等.不同麻醉方法对围手术期应激反应的影响[J].牡丹江医学院学报,2001,22(3):3-6.
[51]陈立武,杜建,黄铭涵,等.Ⅲ期胃肠道肿瘤患者围手术期细胞疫功能的动态观察[J].现代肿瘤医学,2007,15(6):813-815.
[52]Hansbrough J F,Bender EM,Sirvent RZ,et al.Altered helper and suppressor lymphocyte populztions in surgical patients[J].Am J Surg,1984,148:303-305.
[53]焦志华.麻醉、手术对肿瘤患者细胞免疫的影响[J].国外医学麻醉学 与复苏分册,2002,23(5):303-305.
[54]Esposito S.Immune system and surgical site infection[J].J Chemother,2001,13(1):12-16.
[55]陈主初,王树人.病理生理学[M].北京,人民卫生出版社,2001,219-223.
[56]Wang L,Das H,Kamath A,et al.Human V gamma 2V delta2 T cells augment migration-inhibitory factor secretion andcounteract the inhibitory effect of glucocorticoids on IL-1 beta and TNF-alpha production[J].J Immunol,2002,168(10):4889-4896.
[57]徐华.手术应激反应研究进展[J].《国外医学》麻醉学与复苏分册,2003,24(5):278-281.
[58]黄勇,刘建伟.术前一次给予地塞米松对结肠癌患者免疫功能的影响[J].岭南现代临床外科,2008,8(1):26-28
[59]Na YM,Kim MY,Kim YK,et al.Exercise therapy effect on natural killer cell cytotoxic activity in stomach cancer patients after curative surgery[J].Arch Phys Med Rehabil,2000,81:777-779.
[60]Herhman MJ,Cheadle WG,Wellhausen SR,et al.Monocyte HLA2 DR antigen expression characterizes clinical outcome in the trauma patient[J].Br J Surg,1990,77:204.